Accumulating evidence indicates that the phytochemical composition and immune-modulating activity of Echinacea purpurea cannot be fully explained by plant genetics or extraction chemistry alone. Instead, fungal and bacterial endophytes—together with broader soil and rhizosphere conditions—play a decisive role in shaping both the quantity and functional profile of secondary metabolites with clinical relevance. This literature collectively reframes Echinacea as a plant–microbiome system, in which bioactivity emerges from multi-organism interactions rather than from plant metabolism in isolation.
Fungal endophytes and secondary metabolite enhancement
Evidence indicates that fungal endophytes can enhance plant growth and influence secondary metabolite production in Echinacea purpurea under specific experimental conditions, particularly in controlled inoculation and symbiosis studies. In a focused cultivation study, fungal endophyte inoculation was associated with increased biomass and altered production of natural products relative to non-inoculated controls (Gualandi, 2010). Complementary work on arbuscular mycorrhizal symbiosis further demonstrates that fungal colonization can increase growth and modify secondary metabolite profiles in E. purpurea, including compounds relevant to pharmacological activity (Araim et al., 2009).
However, the existing literature does not yet constitute broad, repeated replication across independent fungal taxa, cultivation systems, and experimental designs. Instead, the current evidence supports a conditional and context-dependent effect, in which fungal endophytes can modulate metabolic output and relative compound abundance, suggesting pathway-level influence rather than uniform yield enhancement.
Root-associated bioactivity and host resistance
The implications of endophyte involvement become particularly clear when immune outcomes are examined. Early pharmacological studies reported host-resistance–enhancing activity in Echinacea root extracts (Bodinet et al., 1993), an effect traditionally attributed to alkamides or caffeic acid derivatives. Subsequent research, however, has complicated this narrative.
Work by Haron et al. (2016) demonstrated that immune-enhancing activity in E. purpurea extracts depends strongly on the plant microbiome and is further modulated by soil organic matter content. In that study, macrophage activation via lipopolysaccharide fragments or small peptides could be fully accounted for by bacterial colonizers rather than by classical phytochemicals. This finding challenges the assumption that immune stimulation observed in vitro or in vivo necessarily reflects plant secondary metabolites.
This distinction matters. Immune enhancement and inflammatory amplification are not the same outcome, yet both can arise from microbial products. Without accounting for endophyte contributions, it becomes difficult to interpret whether an extract is supporting immune regulation or merely triggering innate immune activation.
Bacterial endophytes, immune modulation, and soil context
The role of bacterial endophytes in shaping immune activity has been demonstrated most clearly in work linking Echinacea extracts to macrophage activation. Haron et al. (2016) showed that immune-enhancing activity in E. purpurea was dependent on the presence and composition of the plant microbiome and was further modulated by soil organic matter content. This study provided direct evidence that immune activity attributed to Echinacea extracts could be fully accounted for by bacterial colonizers, rather than by classical phytochemicals alone. The implication is that bioactivity can vary dramatically with cultivation conditions that influence microbial communities, even when plant species and extraction methods are held constant.
Leaf microbiota and modulation of chicoric acid
Microbial influence is not confined to roots. Maggini et al. (2019) demonstrated that the leaf-associated microbiota of E. purpurea significantly affected chicoric acid levels, one of the most commonly used marker compounds for identity and quality control. Variations in microbial community composition have been associated with measurable differences in phenylpropanoid-derived compounds across multiple plant systems, consistent with indirect regulation of host phenylpropanoid metabolism via defense signaling and transcriptional reprogramming rather than direct microbial biosynthesis (Badri et al., 2013; Van Wees et al., 2008; Vogel et al., 2016).These finding challenges the reliability of chicoric acid as a purely plant-derived marker and highlights the need to consider microbiome status when interpreting analytical data.
Implications
Clinically relevant phytochemicals in Echinacea purpurea are partially an emergent property of plant–microbe interactions. Fungal endophytes and mycorrhizal symbionts enhance growth and reshape secondary metabolism; bacterial endophytes can dominate immune signaling outcomes; and both root and leaf microbiota influence concentrations of canonical marker compounds such as chicoric acid. Consequently, variability in clinical efficacy and experimental outcomes may reflect differences in microbial ecology as much as differences in extraction method or plant part.
For research, product development, and regulation, this body of work implies that quality control frameworks based solely on phytochemical profiling are mechanistically incomplete. A more robust model must account for endophytic and rhizosphere contributions, cultivation conditions, and processing steps that alter microbial residues or metabolites. Ignoring these factors risks misattributing bioactivity, overgeneralizing clinical claims, and failing to reproduce results across batches or studies.
Remaining Questions
Which Echinacea bioactivities commonly attributed to polyphenols or alkamides are instead driven by fungal or bacterial endophyte products?
To what extent can soil management practices (and indirectly endophyte communities) be intentionally managed to enhance clinical efficacy?
Are current marker compounds (e.g., chicoric acid) reliable indicators of efficacy if their abundance is microbiome-dependent?
How should microbial contributions be treated in regulatory frameworks for botanical products: as contaminants, co-actives, or process-dependent variables?
References
1. Araim, G., Saleem, A., Arnason, J. T., & Charest, C. (2009). Root colonization by an arbuscular mycorrhizal fungus increases growth and secondary metabolism of purple coneflower, Echinacea purpurea (L.) Moench. Journal of Agricultural and Food Chemistry, 57(6), 2255–2260. https://doi.org/10.1021/jf8031055
2. Badri, D. V., Zolla, G., Bakker, M. G., Manter, D. K., & Vivanco, J. M. (2013).
Potential impact of soil microbiomes on the phenylpropanoid metabolism in Arabidopsis roots. Plant Physiology, 163(1), 263–278. https://doi.org/10.1104/pp.113.224055
3. Bodinet, C., Willigmann, I., & Beuscher, N. (1993). Host-resistance increasing activity of root extracts from Echinacea species. Arzneimittelforschung, 43(10), 1037–1041.
4. Gualandi, R. J., Jr. (2010). Fungal endophytes enhance growth and production of natural products in Echinacea purpurea (Moench.) (Master’s thesis). University of Tennessee, Knoxville.
5. Haron, M. H., Tyler, H. L., Chandra, S., Moraes, R. M., Jackson, C. R., Pugh, N. D., & Pasco, D. S. (2016). Plant microbiome-dependent immune enhancing action of Echinacea purpurea is enhanced by soil organic matter content. Scientific Reports, 6, 24178. https://doi.org/10.1038/srep24178
6. Maggini, V., De Leo, M., Granchi, C., Tuccinardi, T., Mengoni, A., Gallo, E. R., … Bogani, P. (2019). The influence of Echinacea purpurea leaf microbiota on chicoric acid level. Scientific Reports, 9, 10250. https://doi.org/10.1038/s41598-019-46601-5
7. Badri, D. V., Zolla, G., Bakker, M. G., Manter, D. K., & Vivanco, J. M. (2013).
Potential impact of soil microbiomes on the phenylpropanoid metabolism in Arabidopsis roots. Plant Physiology, 163(1), 263–278. https://doi.org/10.1104/pp.113.224055
8. Van Wees, S. C. M., Van der Ent, S., & Pieterse, C. M. J. (2008).
Plant immune responses triggered by beneficial microbes. Current Opinion in Plant Biology, 11(4), 443–448. https://doi.org/10.1016/j.pbi.2008.05.005
9. Vogel, C., Bodenhausen, N., Gruissem, W., & Vorholt, J. A. (2016).
The Arabidopsis leaf transcriptome reveals distinct and predictable responses to microbiota colonization. Proceedings of the National Academy of Sciences of the United States of America, 113(41), E6380–E6389. https://doi.org/10.1073/pnas.1608975113
10. Zhao, J., Davis, L. C., & Verpoorte, R. (2010).Elicitor signal transduction leading to production of plant secondary metabolites. Biotechnology Advances, 28(2), 256–267. https://doi.org/10.1016/j.biotechadv.2009.10.001